CISF Interview 2020: UPSC releases schedule on upsc.gov.in, check details here

-

The Union Public Service Commission (UPSC) has put out the interview schedule for the Central Industrial Security Force (CISF) 2020. Candidates appearing for Personality Test or Interview in CISF AC(Exe) LDC Examination can check the notice by visiting the official website of UPSC at https://upsc.gov.in/

The official notice stated that the interview timings and location for the "Central Industrial Security Force (CISF) AC(Exe) LDC Examination, 2020". Shortlisted applicants will have to reach Union Public Service Commission, Dholpur House, Shahjahan Road, New Delhi 110069 on the interview date as per the given schedule in the notice. No changes will be made to the schedule posted by the UPSC.

Check the statement here: https://ift.tt/3hMtdgu

This year a total of 85 aspirants have been shortlisted to appear for the interview round. Moreover, the personality test or interview will be held on 25, 26, 27 and 28 October. As per the schedule, this examination will be conducted in two shifts; the first shift will begin from 9:00 am and the second shift will commence from 1:00 pm every day.

Furthermore, if any candidate faces discrepancy, they may contact the UPSC Facilitation Counter in person or can also call on Telephone numbers -23385271, 23381125 and 23098543. For more related details and information, candidates can check the official site of UPSC at https://upsc.gov.in/

Moreover, the e-Summon Letters of medically fit applicants in PET/PST and MST exams, as well as candidates declared medically fit in RME for personality test or interview, will be made available by the commission in a few days. As the letters are released, aspirants can download them from the Commission’s website which is https://ift.tt/3zm11Y3

Along with their e-Summon Letter, candidates are advised to download its enclosures and keep a printout of the same. They also have to adhere to the instructions given on eSummon letter for appearing in the Personality Test.



from Firstpost India Latest News https://ift.tt/3kjp9WI
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more